Yunnan Jianzhijia Health-Chain Co., Ltd.

Shanghai Stock Exchange 605266.SS

Yunnan Jianzhijia Health-Chain Co., Ltd. Price to Sales Ratio (P/S) on January 27, 2025: 0.37

Yunnan Jianzhijia Health-Chain Co., Ltd. Price to Sales Ratio (P/S) is 0.37 on January 27, 2025, a -49.12% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Yunnan Jianzhijia Health-Chain Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 0.77 on May 14, 2024, which is 105.01% above the current Price to Sales Ratio (P/S).
Yunnan Jianzhijia Health-Chain Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 0.26 on August 28, 2024, which is -29.28% below the current Price to Sales Ratio (P/S).
Yunnan Jianzhijia Health-Chain Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.48.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 605266.SS

Yunnan Jianzhijia Health-Chain Co., Ltd.

CEO	Mr. Bo Lan
IPO Date	Dec. 1, 2020
Location	China
Headquarters	Jianzhijia Office Building
Employees	16,649
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Baby & Childcare Cleaning Supplies Cosmetics Eyewear Personal Care Pharmaceuticals

Description

Yunnan Jianzhijia Health-Chain Co., Ltd. engages in the pharmaceutical retail business in China. The company operates approximately 1,200 direct operated stores, as well as an online pharmacy business. It offers products in the areas of family medicine, contact lens/care solutions, medical instruments, sexual health, nutrition, Chinese herbal medicine, personal care, baby products, and convenience food. The company was founded in 2004 and is based in Kunming, China.

Key trends

Past 5 years